RDNT
RadNet, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$73.71
−1.22%Aug 9, 2026, 20:00 UTC
RadNet reported second quarter 2026 financial results with record quarterly revenue of $622.7 million, up 25.0% year-over-year, and record adjusted EBITDA of $99.7 million, up 22.7%.
Jul 30, 2026, 20:15 UTC
DeepHealth received FDA 510(k) clearance for its AI-powered breast ultrasound solution.
Source:Jun 29, 2026, 14:55 UTC
RadNet's DeepHealth unit received FDA clearances for new AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
Source:Jun 25, 2026, 10:00 UTC
DeepHealth received two FDA 510(k) clearances for new Breast Suite functionalities: BAC Assessment and prior exam integration into ProFound Pro.
Source:Jun 10, 2026, 20:05 UTC
RadNet secured a $250 million incremental term loan and reduced the interest rate on its credit facility by 0.25%.
Source:Jun 10, 2026, 10:00 UTC
DeepHealth launched Reporting Pro, an AI-powered radiology reporting solution.
Source: